Clover has stated that sales of its tuna fish oil and microencapsulated powders will continue to be a focus for the 2009 financial year, especially in the high value children’s formulations market. The company continues to explore key opportunities in the American and European markets which have been largely untapped and represents a key opportunity for the next stage of Clover’s development.
CLV Price at posting:
25.0¢ Sentiment: LT Buy Disclosure: Held
